Form 4 holding
Chief Business and Commercial Officer, Proprietary Drugs
Athenex, Inc.
- Security class
- Common Stock
- Shares / value
- 4,140
- Estimated value
- $5,630
- Report date
- 05 May 2023
- Price
- $1.36
- Ownership
- Direct
Timothy DeVere Cook - Chief Business and Commercial Officer, Proprietary Drugs at Athenex, Inc.
Issuer-level insider activity
- Role
- Chief Business and Commercial Officer, Proprietary Drugs
- Issuer ticker
- ATNXQ
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Timothy DeVere Cook since 14 Sep 2025
Reported holdings for Timothy DeVere Cook in Athenex, Inc.
Form 4 holding
Chief Business and Commercial Officer, Proprietary Drugs
Athenex, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 3,750
- Estimated value
- Report date
- 05 May 2023
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,750
Form 4 holding
Chief Business and Commercial Officer, Proprietary Drugs
Athenex, Inc.
- Security class
- Restricted Stock Units
- Shares / value
- 338
- Estimated value
- Report date
- 05 May 2023
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 338
Transaction history for Timothy DeVere Cook in Athenex, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.